CHI ADVISORS LLC Holdings
CHI ADVISORS LLC is an investment fund managing more than 371.91M US dollars. The largest holdings include Prometheus Biosciences, Pliant Therapeutics and Cullinan Oncology. In Q3 2022 the fund bought assets of total value of 77.12M US dollars and sold assets of total value of 33.91M US dollars.
CHI ADVISORS LLC portfolio value:
CHI ADVISORS LLC quarter portfolio value change:
CHI ADVISORS LLC 1 year portfolio value change:
CHI ADVISORS LLC 3 years portfolio value change:
CHI ADVISORS LLC portfolio changes
Period | Buy | Sel |
---|---|---|
Q4 2019 | 2657000 | 7563000 |
Q1 2020 | -22851000 | 66996000 |
Q2 2020 | 219267000 | 5715000 |
Q3 2020 | 31977000 | 4637000 |
Q4 2020 | 64085000 | 2313000 |
Q1 2021 | 138968000 | 15922000 |
Q2 2021 | -38020000 | 8991000 |
Q3 2021 | -40508000 | 39604000 |
Q4 2021 | -11327000 | 20919000 |
Q1 2022 | -17421000 | 25120000 |
Q2 2022 | 35046000 | 1320000 |
Q3 2022 | 77115000 | 33912000 |
CHI ADVISORS LLC 13F holdings
Stock |
---|
Portfolio share: 25.42% Portfolio value: 94.52M Avg. open price: $36.39 Current price: $40 P/L: +9.92% Sold -4.20% shares Q3 2022 |
Portfolio share: 19.15% Portfolio value: 71.23M Avg. open price: $13.12 Current price: $17.83 P/L: +35.92% Bought +9.75% shares Q3 2022 |
Portfolio share: 11.18% Portfolio value: 41.57M Avg. open price: $16.24 Current price: $12.11 P/L: -25.42% Bought +6.42% shares Q3 2022 |
Portfolio share: 10.01% Portfolio value: 37.23M Avg. open price: $18.1 Current price: $17.32 P/L: -4.33% Bought +15.98% shares Q3 2022 |
Portfolio share: 6.65% Portfolio value: 24.71M Avg. open price: N/A Current price: N/A P/L: N/A Bought +8.92% shares Q3 2022 |
Portfolio share: 4.08% Portfolio value: 15.17M Avg. open price: $13.81 Current price: $7.43 P/L: -46.18% Sold -4.24% shares Q3 2022 |
Portfolio share: 2.94% Portfolio value: 10.92M Avg. open price: $1.96 Current price: $3.16 P/L: +61.22% Bought +125.40% shares Q3 2022 |
Portfolio share: 2.34% Portfolio value: 8.70M Avg. open price: $5.62 Current price: $13.29 P/L: +136.30% Bought +54.09% shares Q3 2022 |
Portfolio share: 2.07% Portfolio value: 7.71M Avg. open price: N/A Current price: $16.04 P/L: N/A Sold -35.31% shares Q3 2022 |
Portfolio share: 2.03% Portfolio value: 7.53M Avg. open price: $40.65 Current price: $51.19 P/L: +25.93% Bought +93.59% shares Q3 2022 |
Portfolio share: 1.73% Portfolio value: 6.45M Avg. open price: N/A Current price: $4.94 P/L: N/A Sold -6.42% shares Q1 2022 |
Portfolio share: 1.54% Portfolio value: 5.72M Avg. open price: N/A Current price: $6.99 P/L: N/A N/A Q3 2021 |
Portfolio share: 1.44% Portfolio value: 5.35M Avg. open price: $4.09 Current price: $1.41 P/L: -65.53% Sold -1.85% shares Q3 2022 |
Portfolio share: 1.28% Portfolio value: 4.77M Avg. open price: $3.07 Current price: $1.34 P/L: -56.41% Bought +22.34% shares Q3 2022 |
Portfolio share: 1.16% Portfolio value: 4.31M Avg. open price: $9.49 Current price: $2.36 P/L: -75.14% Bought +11.31% shares Q3 2022 |
Portfolio share: 1.09% Portfolio value: 4.04M Avg. open price: $10.84 Current price: $6.16 P/L: -43.18% Sold -57.78% shares Q3 2022 |
Portfolio share: 1.07% Portfolio value: 3.99M Avg. open price: $1.95 Current price: $0.46 P/L: -76.48% Bought +50.49% shares Q3 2022 |
Portfolio share: 0.92% Portfolio value: 3.42M Avg. open price: $6.3 Current price: $4.53 P/L: -28.10% Bought +139.53% shares Q3 2022 |
Portfolio share: 0.91% Portfolio value: 3.37M Avg. open price: $2.51 Current price: $0.62 P/L: -75.27% Sold -0.99% shares Q3 2022 |
Portfolio share: 0.76% Portfolio value: 2.81M Avg. open price: N/A Current price: $5.78 P/L: N/A N/A Q3 2022 |
Portfolio share: 0.54% Portfolio value: 2.01M Avg. open price: $10.64 Current price: $0.46 P/L: -95.68% Sold -2.07% shares Q2 2022 |
Portfolio share: 0.52% Portfolio value: 1.95M Avg. open price: $2.53 Current price: $1.02 P/L: -59.62% Bought +7.69% shares Q3 2022 |
Portfolio share: 0.43% Portfolio value: 1.59M Avg. open price: $4.03 Current price: $1.85 P/L: -54.08% Bought +1.40% shares Q2 2022 |
Portfolio share: 0.42% Portfolio value: 1.54M Avg. open price: N/A Current price: $8.59 P/L: N/A Sold -67.15% shares Q3 2022 |
Portfolio share: 0.32% Portfolio value: 1.19M Avg. open price: N/A Current price: $16.5 P/L: N/A N/A Q3 2022 |
Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.07 P/L: N/A Sold -100.00% shares Q3 2022 |
Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $13.81 Current price: $7.43 P/L: -46.18% Sold -100.00% shares Q3 2022 |
Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $6.3 Current price: $4.53 P/L: -28.10% Sold -100.00% shares Q3 2022 |
Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $18.31 P/L: N/A Sold -100.00% shares Q3 2022 |
Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $85.66 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 30 CHI ADVISORS's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of CHI ADVISORS LLC?
The biggest position of the CHI ADVISORS LLC is Prometheus Biosciences, Inc. (RXDX) with 25.42% portfolio share worth of 94.52M US dollars.
Top 5 CHI ADVISORS's holdings represent 72.41% of the portfolio:
- Prometheus Biosciences, Inc. (RXDX) – 25.42%
- Pliant Therapeutics, Inc. (PLRX) – 19.15%
- Cullinan Oncology, Inc. (CGEM) – 11.18%
- Repare Therapeutics Inc. (RPTX) – 10.01%
- VECTIVBIO HLDG AG () – 6.65%
Who is the portfolio manager of CHI ADVISORS LLC?
The portfolio manager of the CHI ADVISORS LLC is .
What is the total asset value of the CHI ADVISORS LLC portfolio?
CHI ADVISORS LLC total asset value (portfolio value) is 371.91M US dollars.
Who is ?
is the portfolio manager of the CHI ADVISORS LLC.
What is (CHI ADVISORS LLC) fund performance?
CHI ADVISORS's quarterly performance is +35.74%, annualy -16.44%. In the past 3 years, the value of 's portfolio has decreased by -216%.
What is the CHI ADVISORS LLC CIK?
CHI ADVISORS's Central Index Key is 0001791468 .